DJIA 17,813.21 -1.73 -0.01%
NASDAQ 4,782.41 24.15 0.51%
S&P 500 2,070.94 3.91 0.19%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

59.72 0.38 (0.63%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MRK $59.72 0.63%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $59.70
Previous Close $59.34
Daily Range $59.35 - $59.77
52-Week Range $47.61 - $61.33
Market Cap $170.2B
P/E Ratio 32.25
Dividend (Yield) $1.76 (3.0%)
Ex-Dividend Date
Dividend Pay Date
12/11/14
01/08/15
Volume 3,653,906
Average Daily Volume 12,257,772
Current FY EPS $3.49

Sector

Healthcare

Industry

Drugs

Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website: http://www.merck.com/

News & Commentary Rss Feed

Should Gilead Sciences, Inc. Pay a Dividend?

Shares of Gilead Sciences have skyrocketed over the past two years, propelling the company into the upper echelons of the healthcare sector in terms of market cap. With all of its new peer group offering a dividend, should Gilead follow suit?

Why A Merck Clinical Trial May Help Amgen And Regeneron Shares To Set Higher Highs

Daily Dividend Report: MRK, CBS, ADI, BDC, FGP

Merck Buys Rights to Ebola Vaccine Candidate from NewLink - Analyst Blog

Rolling With Biotech's Regulatory Punches: Chen Lin

Merck Enters Ebola Vaccine Race

How to Make Money Day Trading

Ignore the naysayers: Day trading could bring you great wealth.

3 Stocks Reiterated As A Buy: MA, MRK, HD

Merck obtains right to experimental Ebola vaccine

Big News for Ebola Stocks

See More MRK News...

MRK's Top Competitors

MRK $59.72 (0.63%)
Current stock: MRK
JNJ $107.11 (0.38%)
Current stock: JNJ
NVS $95.58 (0.57%)
Current stock: NVS
PFE $31.11 (2.08%)
Current stock: PFE